JAMA Network Home
Sign In
Research Letter

Novel Drug Launches in Most-Favored-Nation Countries and Medicare Pricing Benchmarks

JAMA Health Forum 10.1001/jamahealthforum.2026.2340

July 31, 2026 at 11:00 AM EDT

Read the full article

This cross-sectional study examines the time to market launch for recently approved therapeutics likely eligible for 2 new mandatory service and delivery models in most-favored-nation countries following US launch.

Corresponding Author: Joseph S. Ross, MD, MHS, Section of General Internal Medicine, Department of Medicine, Yale School of Medicine, 367 Cedar St, Harkness 4A-405, New Haven, CT 06520 (joseph.ross@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2026.2340?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=073126

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks